Interestingly, previous studies have shown that GATA2 and FOXA1 co-occupy 55% of all hormone-responsive AR binding sites in the LNCaP prostate cancer cell line, suggesting a potential cooperative mechanism between these two pioneer transcription factors in regulating the AR cistrome (45). Here, GATA2 is linked to prostate cancer.